Express Scripts dropped Advair, a popular asthma drug, and offered its customers Symbicort instead. As a result, Glaxo dropped the price of Advair and Symbicort went down, too. This is a welcome development.
(To read the full NPR article, click on the above graph.)

No comments:
Post a Comment